Jefferies Group’s Globus Medical GMED Stock Holding History

Jefferies Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-25,000	Closed	-$1.26M	–	2517
2018 Q2	$1.26M	Buy	+25,000	New	+$1.3M	0.01%	1127

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Jefferies Group's GMED Position: Q1 2020 in Review

Jefferies Group sold out of Globus Medical (GMED) in Q1 2020, closing a stake of 6,657 shares — an estimated $392K sold.

Jefferies Group first reported a position in GMED in Q2 2015 and held it in 6 quarters. The position peaked at $397K in Q3 2019. 273 funds tracked by Wall St. Rank hold GMED as of Q1 2020.

Jefferies Group reported no remaining Globus Medical position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 6,657 Globus Medical shares in Q1 2020, an estimated $392K.
Jefferies Group first reported a position in Globus Medical in Q2 2015 and held it in 6 quarters.
Jefferies Group's Globus Medical position peaked at $397K in Q3 2019.
273 funds tracked by Wall St. Rank held Globus Medical as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.